EU Authorizes Mpox Vaccine for Toddlers, Closing Deadly Gap for DRC Children
The European Commission granted marketing authorization for Bavarian Nordic's IMVANEX mpox and smallpox vaccine to cover children aged 2 to under 12 years — the first time any major regulatory authority has formally cleared a non-replicating mpox …